SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 149 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 660 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 660 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 660 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -83.3% | 660 | -76.9% | 0.00% | – |
| Q4 2017 | $6,000 | +500.0% | 2,860 | +748.7% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 337 | -57.3% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 789 | +3.5% | 0.00% | – |
| Q4 2015 | $4,000 | 0.0% | 762 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | -33.3% | 762 | +3.4% | 0.00% | – |
| Q2 2015 | $6,000 | +500.0% | 737 | +130.3% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 320 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 320 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 320 | 0.0% | 0.00% | – |
| Q2 2014 | $1,000 | -50.0% | 320 | 0.0% | 0.00% | – |
| Q1 2014 | $2,000 | – | 320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
| Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
| Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
| Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
| Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
| KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
| Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |